Cambridge startup analyses ‘multi-omics’ data to discover new heart drugs
Update: 2024-09-10
Description
Cambridge-based CardiaTec has raised $6.5mn to accelerate drug discovery for cardiovascular diseases, such as heart attacks and strokes. Cardiovascular diseases are the leading cause of death globally, claiming the lives of 17.9 million people each year. Yet our knowledge of their underlying biology is still limited, hindering the effectiveness of clinical trials and drug solutions. CardiaTec aims to address this knowledge gap with a drug discovery platform that leverages AI to analyse human tissue “multi-omics” data. Mutli-omics is a biological analysis approach which combines the study of multiple “omes,” the sets of various biological molecules or entities within a cell…
This story continues at The Next Web
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
